What Researchers Did
This narrative review aimed to elucidate the mechanisms of action underlying Hyperbaric Oxygen Therapy (HBOT), focusing on oxy-inflammation in various pathologies.
What They Found
The review discussed Hyperbaric Oxygen Therapy (HBOT) as a non-invasive method delivering 100% O2 at pressures between 1.5 and 3.0 ATA for 60 to 120 minutes. It highlighted 15 approved indications for HBOT, categorized into emergency medicine, wound healing acceleration, and antimicrobial effects, and explored the role of oxy-inflammation in these applications.
What This Means for Canadian Patients
Canadian patients undergoing Hyperbaric Oxygen Therapy (HBOT) can gain a better understanding of the scientific mechanisms, including oxy-inflammation, that contribute to its therapeutic effects. This knowledge may help patients and clinicians appreciate the rationale behind HBOT protocols for conditions like wound healing or certain emergencies.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a narrative review, this study's findings are limited by the subjective selection and interpretation of existing literature rather than a systematic analysis.